GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » EV-to-FCF

Getinge AB (Getinge AB) EV-to-FCF : 16.61 (As of Jun. 19, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Getinge AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Getinge AB's Enterprise Value is $5,109 Mil. Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $308 Mil. Therefore, Getinge AB's EV-to-FCF for today is 16.61.

The historical rank and industry rank for Getinge AB's EV-to-FCF or its related term are showing as below:

GNGBF' s EV-to-FCF Range Over the Past 10 Years
Min: 9.25   Med: 20.39   Max: 66.8
Current: 16.79

During the past 13 years, the highest EV-to-FCF of Getinge AB was 66.80. The lowest was 9.25. And the median was 20.39.

GNGBF's EV-to-FCF is ranked better than
66.48% of 358 companies
in the Medical Devices & Instruments industry
Industry Median: 26.665 vs GNGBF: 16.79

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Getinge AB's stock price is $21.17. Getinge AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.788. Therefore, Getinge AB's PE Ratio for today is 26.87.


Getinge AB EV-to-FCF Historical Data

The historical data trend for Getinge AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB EV-to-FCF Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.68 9.25 19.23 26.66 41.57

Getinge AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.69 43.34 41.13 41.57 19.59

Competitive Comparison of Getinge AB's EV-to-FCF

For the Medical Devices subindustry, Getinge AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Getinge AB's EV-to-FCF falls into.



Getinge AB EV-to-FCF Calculation

Getinge AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5108.881/307.639
=16.61

Getinge AB's current Enterprise Value is $5,109 Mil.
Getinge AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $308 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB  (OTCPK:GNGBF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Getinge AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.17/0.788
=26.87

Getinge AB's share price for today is $21.17.
Getinge AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.788.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Getinge AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Getinge AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB (Getinge AB) Business Description

Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.